Resistance mechanisms against osimertinib in lung adenocarcinoma cells with EGFR-activating mutation

被引：0
|
作者：
Nishihara, Shigetoshi [1 ,2 ]
Yamaoka, Toshimitsu [1 ,3 ]
Hasebe, Yuki [1 ]
Ishikawa, Fumihiro [4 ]
Kusumoto, Sojiro [3 ]
Ohmori, Tohru [3 ]
Sagara, Hironori [3 ]
Yoshida, Hitoshi [2 ]
Tsurutani, Junjii [1 ]
机构：
[1] Showa Univ, Adv Canc Trans Res Inst, Tokyo, Japan
[2] Showa Univ, Div Gastroenterol, Dept Med, Med Sch, Tokyo, Japan
[3] Showa Univ, Div Allergol & Respi Med, Dept Med, Med Sch, Tokyo, Japan
[4] Showa Univ, Ctr Biotechnol, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2365
引用
收藏
页码：1494 / 1494
页数：1
相关论文
共 50 条
  • [41] B7–H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression
    Youwei Lu
    Fengying Wu
    Qiuyi Cao
    Yu Sun
    Moli Huang
    Jing Xiao
    Bin Zhou
    Liang Zhang
    Oncogene, 2022, 41 : 704 - 717
  • [42] Heterogeneity of resistance mechanisms in lung adenocarcinoma patients with acquired resistance to EGFR inhibitors
    Mu, Xinmeng Jasmine
    Van Allen, Eli
    Wagle, Nikhil
    Chong, Curtis
    Butaney, Mohit
    Farlow, Deborah
    Getz, Gad
    Jaenne, Pasi A.
    Garraway, Levi A.
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
    Roper, Nitin
    Brown, Anna-Leigh
    Wei, Jun S.
    Pack, Svetlana
    Trindade, Christopher
    Kim, Chul
    Restifo, Olivia
    Gao, Shaojian
    Sindiri, Sivasish
    Mehrabadi, Farid
    El Meskini, Rajaa
    Ohler, Zoe Weaver
    Maity, Tapan K.
    Venugopalan, Abhilash
    Cultraro, Constance M.
    Akoth, Elizabeth
    Padiernos, Emerson
    Chen, Haobin
    Kesarwala, Aparna
    Smart, DeeDee K.
    Nilubol, Naris
    Rajan, Arun
    Piotrowska, Zofia
    Xi, Liqiang
    Raffeld, Mark
    Panchenko, Anna R.
    Sahinalp, Cenk
    Hewitt, Stephen
    Hoang, Chuong D.
    Khan, Javed
    Guha, Udayan
    CELL REPORTS MEDICINE, 2020, 1 (01)
  • [44] Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma
    Zhang, Tuo
    Sun, Beibei
    Zhong, Chenxi
    Xu, Ke
    Wang, Zhexin
    Hofman, Paul
    Nagano, Tatsuya
    Legras, Antoine
    Ricciuti, Biagio
    Breadner, Daniel
    Divisi, Duilio
    Schmid, Ralph A.
    Peng, Ren-Wang
    Yang, Haitang
    Yao, Feng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (04) : 1857 - 1872
  • [45] The clinical outcome of stage I lung adenocarcinoma patients with or without activating EGFR mutation
    Fang, Yueh-Fu
    CANCER RESEARCH, 2017, 77
  • [46] Clinical Management in NSCLC Patients With EGFR Mutation After Osimertinib Progression With Unknown Resistance Mechanisms
    Liao, Xin
    He, Tingting
    Wan, Xiong
    Liu, Pian
    Li, Jing
    He, Yong
    Wang, Yubo
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (10):
  • [47] A man with back pain and a mass in the lung -: Poorly differentiated adenocarcinoma of the lung, with an activating mutation in the EGFR gene
    Sequist, Lecia V.
    Settleman, Jeffrey E.
    Ackman, Jeanne B.
    Iafrate, A. John
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04): : 405 - 414
  • [48] Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study
    Xiaoyang Zhai
    Wanhu Li
    Ji Li
    Wenxiao Jia
    Wang Jing
    Yaru Tian
    Shuhui Xu
    Yuying Li
    Hui Zhu
    Jinming Yu
    Radiation Oncology, 16
  • [49] Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study
    Zhai, Xiaoyang
    Li, Wanhu
    Li, Ji
    Jia, Wenxiao
    Jing, Wang
    Tian, Yaru
    Xu, Shuhui
    Li, Yuying
    Zhu, Hui
    Yu, Jinming
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [50] CNS Metastases of Pulmonary Adenocarcinoma Harboring EGFR-Activating Mutations: a Multidisciplinary Approach, Including EGFR-TKis
    Harada, G.
    Bonadio, R.
    Marta, G.
    Takahashi, T.
    Takagaki, T.
    De Castro, G., Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2226 - S2227
12345